Nemluvio was well tolerated and showed sustained improvements in moderate to severe prurigo nodularis during a 2-year treatment period, according to long-term extension data presented at the ...

Lichen planus pigmentosus (LPP) is a rare variant of lichen planus, characterized by chronic acquired hyperpigmented, dark brown to grey, macular pigmentation located on sun-exposed areas of the face, ...

Construction on Mars: NASA Suggests a Synthetic Lichen to Autonomously Convert Regolith into Building Material Ryan Whalen · June 26, 2025 During crewed Mars missions in the coming years, finding ways ...

In Japan, nemolizumab is marketed as Mitchga ® and is approved for the treatment of prurigo nodularis, as well as pruritus associated with atopic dermatitis in pediatric, adolescent, and adult ...

Galderma has reported new interim analysis data from the OLYMPIA long-term extension trial of monoclonal antibody Nemluvio for the treatment of moderate-to-severe prurigo nodularis (PN), a chronic ...

Nemolizumab significantly and safely improved itch and skin lesions for up to 2 years in patients with moderate to severe prurigo nodularis.

The drug already holds approvals to treat prurigo nodularis, as well as atopic dermatitis, another chronic skin condition. Commenting on the latest results for the drug, Baldo Scassellati Sforzolini, ...

Galderma (SIX: GALD) today announced data from a new interim analysis of a study investigating the long-term safety and efficacy of Nemluvio in moderate-to-severe prurigo nodularis.